Login
Companies $INM
$19.87 +$1.27 (6.83%) Close
InMed Pharmaceuticals Inc. logo

InMed Pharmaceuticals Inc.

inmedpharma.com

What Do They Do?

Develops proprietary small-molecule drug candidates for potential treatments of Alzheimer’s disease, dry age-related macular degeneration and epidermolysis bullosa.

How Do They Make Money?

FY2025 revenue

How Are They Changing?

Since the FY2026 annual report
  • Nov 6, 2026 Completed merger with Mentari Therapeutics The combined company was renamed Mentari Therapeutics and remains focused on developing therapies for migraine prevention.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support